体外光分离置换疗法治疗类固醇难治性移植物抗宿主病的模式：一项德尔菲研究。 - Suppr

Treatment patterns of extracorporeal photopheresis in steroid-refractory graft versus host disease: A delphi study.

作者信息

Penack Olaf, Bacigalupo Andrea, Gavriilaki Eleni, Greinix Hildegard, Malard Florent, Michonneau David, Olivieri Attilio, Peric Zinaida, Sala Elisa, Solano Carlos, Wolff Daniel, Zeiser Robert

机构信息

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Tumorimmunology, Augustenburger Platz 1, 13353, Berlin, Germany.

Fondazione Policlinico Universitario A. Gemelli, Roma, Italy.

出版信息

Bone Marrow Transplant. 2025 Jul 22. doi: 10.1038/s41409-025-02687-y.

DOI:10.1038/s41409-025-02687-y

PMID:40696076

Abstract

摘要

相似文献

Treatment patterns of extracorporeal photopheresis in steroid-refractory graft versus host disease: A delphi study.

Bone Marrow Transplant. 2025 Jul 22. doi: 10.1038/s41409-025-02687-y.

Systematic Review and Meta-Analysis of Extracorporeal Photopheresis for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease.

Transplant Cell Ther. 2025 Feb;31(2):76.e1-76.e13. doi: 10.1016/j.jtct.2024.11.004. Epub 2024 Nov 12.

Lower incidence of chronic graft--host disease after ruxolitinib plus extracorporeal photopheresis versus ruxolitinib alone in steroid-refractory acute graft--host disease following allogeneic stem cell transplantation.

Haematologica. 2025 Jul 1;110(7):1536-1544. doi: 10.3324/haematol.2024.286824. Epub 2025 Mar 20.

Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.

Cochrane Database Syst Rev. 2015 Dec 15;2015(12):CD009759. doi: 10.1002/14651858.CD009759.pub3.

Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.

Cochrane Database Syst Rev. 2015 Dec 15;2015(12):CD009898. doi: 10.1002/14651858.CD009898.pub3.

Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.

Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD009759. doi: 10.1002/14651858.CD009759.pub4.

Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.

Cochrane Database Syst Rev. 2022 Jun 9;6(6):CD009898. doi: 10.1002/14651858.CD009898.pub4.

Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease.

Biol Blood Marrow Transplant. 2020 Apr;26(4):651-658. doi: 10.1016/j.bbmt.2019.12.769. Epub 2020 Jan 7.

The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.

Curr Res Transl Med. 2020 Apr;68(2):71-76. doi: 10.1016/j.retram.2019.10.001. Epub 2019 Oct 17.

Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study.

Transfus Apher Sci. 2021 Oct;60(5):103243. doi: 10.1016/j.transci.2021.103243. Epub 2021 Aug 13.

本文引用的文献

Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.

Lancet Haematol. 2024 Feb;11(2):e147-e159. doi: 10.1016/S2352-3026(23)00342-3. Epub 2024 Jan 3.

Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape.

Leukemia. 2022 Nov;36(11):2558-2566. doi: 10.1038/s41375-022-01701-2. Epub 2022 Sep 24.

Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis.

Front Immunol. 2022 Aug 4;13:954268. doi: 10.3389/fimmu.2022.954268. eCollection 2022.

Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium.

Blood Adv. 2021 Oct 26;5(20):4278-4284. doi: 10.1182/bloodadvances.2021004941.

Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis.

Br J Haematol. 2021 Nov;195(3):429-432. doi: 10.1111/bjh.17700. Epub 2021 Jul 12.

Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.

JAMA Netw Open. 2021 Jan 4;4(1):e2034750. doi: 10.1001/jamanetworkopen.2020.34750.

Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness.

Blood. 2020 Oct 22;136(17):1903-1906. doi: 10.1182/blood.2020007336.

Extracorporeal Photopheresis in Graft-versus-Host Disease.

Transfus Med Hemother. 2020 Jun;47(3):214-225. doi: 10.1159/000508169. Epub 2020 May 19.

Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: a single-center experience.

Transfusion. 2018 Aug;58(8):1973-1979. doi: 10.1111/trf.14649. Epub 2018 Apr 29.

Vascular access considerations for extracorporeal photopheresis.

Transfusion. 2018 Feb;58 Suppl 1:590-597. doi: 10.1111/trf.14500.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Treatment patterns of extracorporeal photopheresis in steroid-refractory graft versus host disease: A delphi study.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Treatment patterns of extracorporeal photopheresis in steroid-refractory graft versus host disease: A delphi study.

作者信息

机构信息

出版信息

相似文献

本文引用的文献